| Literature DB >> 35978643 |
Bin Yan1,2,3, Hui-Xian Miao4, You Wang1,2,3, Jia-Mu Xu1,2,3, Xiu-Qing Lu1, Wan-Hong He1, Wen Di1,2,3, Wei-Hua Lou1,2,3.
Abstract
Objective: To compare hysterectomy by transvaginal natural orifice transluminal endoscopic surgery (VNOTES) versus transumbilical laparoscopic single-site surgery (LESS) as a minimal invasive technique. Materials and Method. The women undergoing hysterectomy for benign diseases by VNOTES and LESS from January 2020 to June 2021 in a tertiary hospital in Shanghai were retrospectively analyzed.Entities:
Mesh:
Year: 2022 PMID: 35978643 PMCID: PMC9377874 DOI: 10.1155/2022/8246761
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.246
Baseline characteristics of the population.
| VNOTES∗ ( | LESS ( |
| |
|---|---|---|---|
| Age (years) | 53.04 ± 9.44 | 54.26 ± 10.33 | 0.27 |
| BMI (kg/m2) (range) | 23.96 ± 3.08 | 24.26 ± 3.84 | 0.48 |
| Prior vaginal birth, | 155 (67.98) | 80 (62.02) | 0.25 |
| Previous abdominal surgery, | 84 (36.84) | 59 (45.74) | 0.10 |
| Cardiovascular disease, | 41 (17.98) | 32 (24.81) | 0.13 |
| Diabetes, | 13 (5.70) | 5 (3.88) | 0.45 |
| Indication for surgery, | |||
| Atypical endometrial hyperplasia | 16 (7.02) | 5 (3.91) | 0.23 |
| Adenomyosis | 36 (15.79) | 13 (10.16) | 0.13 |
| Uterine myoma | 84 (36.84) | 62 (48.44) | 0.04 |
| Cervical dysplasia | 68 (29.82) | 18 (14.07) | <0.001 |
| Treatment-resistant DUB | 2 (0.88) | 4 (3.13) | 0.20 |
| Benign adnexal tumor | 11 (4.82) | 26 (20.16) | <0.001 |
| Uterine prolapse | 11 (4.82) | 1 (0.78) | 0.02 |
DUB: dysfunctional uterine bleeding; SD: standard deviation. ∗The 4 conversions were not included.
Main outcomes in the population.
| VNOTES ( | LESS ( |
| |
|---|---|---|---|
| Uterine weight (g), median (±IQR) | 164.00 (±224.00) | 176.90 (±254.00) | 0.58 |
| Uterine weight > 400 g, | 31 (13.6) | 21 (16.3) | 0.48 |
| Total operating time (min), mean (±SD) | 78.21 ± 30.79 | 112.09 ± 44.05 | <0.001 |
| Blood loss (ml), median (±IQR) | 50 (±10) | 50 (±50) | 0.25 |
| Duration of anal exhaust (hours) (±SD) | 18.80 ± 6.60 | 36.49 ± 13.71 | <0.001 |
| VAS pain score, mean (±IQR) | 0 (0-0) | 0.5 (0-5) | <0.001 |
| Hospital stay (d), median (±IQR) | 2.31 ± 0.69 | 3.77 ± 1.57 | <0.001 |
| Postoperative analgesics use, | 10 (4.39) | 20 (15.50) | <0.001 |
| Complications, | 0 (0) | 0 (0) | — |
| Wound infection, | 0 (0) | 2 (1.55) | 0.13 |
| Readmission after 6 weeks, | 0 (0) | 0 (0) | — |
Figure 1Raw operation time (OT) of 228 patients in a chronological order.
Figure 2(a) The CUSUMOT values of operation time in four phases. (b) The best fit curve for each phase.
Interphase comparison of patient characteristics and postoperative outcomes.
| Phase I ( | Phase II ( | Phase III ( | Phase IV ( |
| |
|---|---|---|---|---|---|
| BMI (kg/m2) | 24.01 ± 2.74 | 24.32 ± 3.46 | 22.57 ± 2.27 | 24.06 ± 2.93 | 0.09 |
| Uterine weight (g) | 158.92 ± 134.60 | 195.96 ± 154.25 | 423.27 ± 338.14 | 214.30 ± 171.89 | <0.001 |
| Operation time (min) | 82.81 ± 31.45 | 72.48 ± 23.66 | 103.77 ± 45.69 | 73.18 ± 26.89 | <0.001 |
| Blood loss (ml) | 50.00 ± 30 | 50.00 ± 20 | 50.00 ± 113 | 50.00 ± 18 | 0.01∗ |
| Postoperative stay (days) | 2.23 ± 0.43 | 2.52 ± 0.94 | 2.20 ± 0.41 | 2.14 ± 0.43 | 0.12 |
∗There was significant difference between phases I, II, III, and phase IV.
Figure 3(a) Graph of raw uterine weight plotted against a chronological case number (228 consecutive patients). (b) The average uterine weight in four phases.